Caeruleus Genomics has developed a proprietary discovery platform to profile disease multimodally and with unprecedented accuracy. To do this, we overcame the core bottlenecks to industrialising single-cell long-read sequencing. 

We use our in-house computational and sequencing platform to profile human tissues functionally, uncover new RNA targets and develop more effective therapies in oncology and rare diseases. 

Spun out from Oxford University by experts in functional genomics, therapeutic target discovery and computational biology.

Caeruleus Genomics

Org chart

Similar companies